Indications and Complications of Androgen Deprivation Therapy.


Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 11 8 2020
medline: 12 10 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

To review the indications for and side effects of androgen deprivation therapy (ADT) in men affected by prostate cancer. National guidelines, evidence-based summaries, peer-reviewed studies, and websites. Indications for ADT include men with (1) intermediate- to high-risk localised prostate cancer undergoing radiation therapy, (2) biochemical recurrence after radical prostatectomy treated with salvage radiation therapy, or (3) metastatic prostate cancer. Several forms of ADT are available. To support self-management, body weight, diet, physical activity, alcohol consumption, and smoking should be discussed during clinical consultations. Important side effects of ADT may include flare-up phenomena of GnRH analogues, local reactions at injection sites, cardiovascular events, bone loss/fractures, drug-drug interactions, urinary tract dysfunction, hot flashes, cognitive impairment, seizure falls, and liver impairment. Nurses have a role in personalized cancer care and should be familiar with indications, side effects, and interventions to optimize quality of life for men affected by prostate cancer receiving ADT.

Identifiants

pubmed: 32773255
pii: S0749-2081(20)30057-7
doi: 10.1016/j.soncn.2020.151042
pii:
doi:

Substances chimiques

Androgen Antagonists 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151042

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Christian Daniel Fankhauser (CD)

Department of Urology, University Hospital, University of Zürich, Zürich, Switzerland.

Marian Severin Wettstein (MS)

Department of Urology, University Hospital, University of Zürich, Zürich, Switzerland.

Michèle Reinhardt (M)

Department of Urology, University Hospital, University of Zürich, Zürich, Switzerland.

Axel Gessendorfer (A)

XUND Bildungszentrum Gesundheit Zentralschweiz, Luzern, Switzerland.

Hugh Mostafid (H)

Department of Urology, Royal Surrey Hospital, Guildford, Surrey, UK. Electronic address: Hugh.Mostafid@nhs.net.

Thomas Hermanns (T)

Department of Urology, University Hospital, University of Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH